Corinne TORTORELLI

Corinne TORTORELLI began their career in 2003 as an Intern in specialized Pharmacy in Research at the Department of Dermatology University Hospital of Besançon. In 2008, they joined L'Oréal as a Head of Clinical Evaluation R&I (Advanced Research) and Project Leader R&I. From 2014 to 2015, they worked at Novartis as a Medical Advisor- Oncology/Rare Tumors. From 2015 to 2017, they worked at Vifor Pharma as a Medical Scientific Liaison on supportive care (oncology, gastrology and heart failure). Since 2017, they have been working at Takeda Oncology as a Senior Medical and Scientific Liaison in Onco-hematology & MSL Manager. Currently, they are a Senior Medical Lead at Brenus Pharma, where they are accompanying the development of a MTI (medicament de thérapie innovante) with an innovative immunotherapy technology that has shown promising pre-clinical results.

Corinne Tortorelli has a diverse educational background. Corinne obtained their Docteur en pharmacie from Universit\u00e9 Paris-Saclay in 2002, followed by a Sciences & Medical Biology Master from UFR Orsay in 2004 and an Oncology certification from Institut Pasteur in 2002. Corinne then went on to pursue a Ph.D in Sciences Life and Internship in University Hospital of Besan\u00e7on from 2002 to 2008. Most recently, they are currently enrolled in an Executive Master Gestion & Politique de Sant\u00e9 at Sciences Po from 2020 to 2022, with a focus on Politique de Sant\u00e9/Affaires Publiques.